The team at Mater Research have started 2020 with a number of success stories from awards to promotions and new appointments our research team have been busy—and it’s only the third week of January.
Allison Pettit was successful in her recent application for promotion to Professor. Professor Pettit is the Director of Biomedical Research, Group Leader of the Bones & Immunology Research Group and an Australian Research Council Fellow.
She has led multidisciplinary research and discoveries across the fields of immunology, rheumatology, cancer biology, haematology and bone biology. Her research has also received both national and international recognition and her work fosters great collaboration across a vast network of biomedical and clinical avenues across the globe.
Alison’s promotion is evidence of her commitment to her field and her outstanding leadership qualities and she was recently awarded the UQ Faculty of Medicine Leader of the Year Award Academic. She has a strong track record of teaching and higher degree student supervision and has been a mentor to many.
“It is particularly important for me to be a role model to women in science, coach them to develop their skills, encourage them to stretch their horizons, accelerate their success pathway and continuously remind them that a STEM career can change the world for the better in multiple ways,” Alison said.
Professor David McIntyre has been awarded the John H. Tyrer Prize in Internal Medicine (2019) from The University of Queensland in recognition of his outstanding contribution to the discipline of internal medicine and research.
The award recognises David’s contribution to internal medicine carried out in Queensland over the past five years and was voted on by his peers and colleagues.
In other news, Professor Ross Pinkerton has taken the position of Mater Human Research Ethics Committee Chair. He is currently the Medical Lead at Hummingbird House Children’s Hospice and a Professor of Oncology at the University of Queensland.
Ross has previously held the role of Director of Cancer Services at Mater whilst also having a conjoint role at Mater Research during this time. In 2007 he was appointed as the Director of Oncology at the Queensland Children’s Cancer Centre after the merging of the cancer services of both the Mater Children’s Hospital and the Royal Children’s Hospital.
In his upcoming role as Chair of the Mater Human Research Ethics Committee, he looks forward to bringing his experience to help facilitate the highest level of research, with transparency and integrity and adhering to the Mater Values.
Mater Research is looking forward to an exciting and challenging year ahead.